开云app官网登录入口网页版-官方正版

#新冠病毒抗体#

14篇内容 | 936人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2005034, encodeId=2014200503488, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, objectTitle=Nature：感染后产生的新冠病毒抗体，却成了导致重症和死亡的帮凶？, objectType=article, longId=724302, objectId=0ce0e24302f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ce0e24302f8, replyNumber=0, likeNumber=0, createdTime=2022-09-20, rootId=0, userName=vera_1203, userId=644e456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ce0e24302f8, moduleTitle=Nature：感染后产生的新冠病毒抗体，却成了导致重症和死亡的帮凶？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0ce0e24302f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005033, encodeId=ad2a200503336, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, objectTitle=JAMA子刊：通过母乳将新冠病毒抗体传递给宝宝，孕妈妈该接种哪种疫苗？, objectType=article, longId=300849, objectId=c63f30084914, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c63f30084914, replyNumber=0, likeNumber=90, createdTime=2022-10-28, rootId=0, userName=vera_1203, userId=644e456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c63f30084914, moduleTitle=JAMA子刊：通过母乳将新冠病毒抗体传递给宝宝，孕妈妈该接种哪种疫苗？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c63f30084914)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005031, encodeId=6766200503154, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, objectTitle=Lancet：重磅！仅2.7%的武汉人群产生有效新冠病毒抗体, objectType=article, longId=208738, objectId=330b208e38ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=330b208e38ab, replyNumber=0, likeNumber=0, createdTime=2021-09-04, rootId=0, userName=vera_1203, userId=644e456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=330b208e38ab, moduleTitle=Lancet：重磅！仅2.7%的武汉人群产生有效新冠病毒抗体, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=330b208e38ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005032, encodeId=610e200503264, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, objectTitle=2021年3月20日全球新冠肺炎（COVID-19）疫情简报，确诊超1亿2286万，新冠病毒抗体可能维持达9个月，印度疫苗接种提速, objectType=article, longId=208750, objectId=ee8d208e508d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee8d208e508d, replyNumber=0, likeNumber=55, createdTime=2021-07-08, rootId=0, userName=vera_1203, userId=644e456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee8d208e508d, moduleTitle=2021年3月20日全球新冠肺炎（COVID-19）疫情简报，确诊超1亿2286万，新冠病毒抗体可能维持达9个月，印度疫苗接种提速, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ee8d208e508d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005026, encodeId=ec28200502687, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, objectTitle=君实与礼来制药达成2.55亿美元新冠病毒抗体授权合作！, objectType=article, longId=193477, objectId=8a501934e783, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a501934e783, replyNumber=0, likeNumber=58, createdTime=2020-10-22, rootId=0, userName=vera_1203, userId=644e456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a501934e783, moduleTitle=君实与礼来制药达成2.55亿美元新冠病毒抗体授权合作！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8a501934e783)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005027, encodeId=8fbe200502eef, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, objectTitle=罗氏新冠病毒抗体检测技术获美国FDA紧急使用授权, objectType=article, longId=193509, objectId=566119350927, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=566119350927, replyNumber=0, likeNumber=92, createdTime=2021-03-13, rootId=0, userName=vera_1203, userId=644e456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=566119350927, moduleTitle=罗氏新冠病毒抗体检测技术获美国FDA紧急使用授权, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=566119350927)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005022, encodeId=bbe0200502218, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, objectTitle=bioRxiv：科学家成功分离高效抗新冠病毒抗体, objectType=article, longId=191153, objectId=261619115349, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=261619115349, replyNumber=0, likeNumber=53, createdTime=2020-08-25, rootId=0, userName=vera_1203, userId=644e456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=261619115349, moduleTitle=bioRxiv：科学家成功分离高效抗新冠病毒抗体, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=261619115349)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005023, encodeId=56752005023ce, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, objectTitle=新冠病毒抗体检测，你知道对疫情防控有多重要吗？, objectType=article, longId=191949, objectId=271e19194959, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=271e19194959, replyNumber=0, likeNumber=66, createdTime=2020-05-09, rootId=0, userName=vera_1203, userId=644e456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=271e19194959, moduleTitle=新冠病毒抗体检测，你知道对疫情防控有多重要吗？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=271e19194959)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005024, encodeId=7d682005024a0, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, objectTitle=三星制药和Vir生物技术公司签署了大规模生产新冠病毒抗体的协议，以治疗COVID-19, objectType=article, longId=192012, objectId=937719201220, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=937719201220, replyNumber=0, likeNumber=65, createdTime=2021-02-03, rootId=0, userName=vera_1203, userId=644e456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=937719201220, moduleTitle=三星制药和Vir生物技术公司签署了大规模生产新冠病毒抗体的协议，以治疗COVID-19, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=937719201220)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005030, encodeId=04b92005030fe, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, objectTitle=EClinicalMedicine：老年人产生新冠病毒抗体的能力不输年轻人, objectType=article, longId=203000, objectId=8cda2030007d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8cda2030007d, replyNumber=0, likeNumber=56, createdTime=2020-12-07, rootId=0, userName=vera_1203, userId=644e456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8cda2030007d, moduleTitle=EClinicalMedicine：老年人产生新冠病毒抗体的能力不输年轻人, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8cda2030007d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005021, encodeId=d2ec2005021f2, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, objectTitle=首批自主研发的新冠病毒抗体化学发光法检测试剂盒获准上市, objectType=article, longId=189471, objectId=1d791894e1b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d791894e1b4, replyNumber=0, likeNumber=51, createdTime=2020-11-29, rootId=0, userName=vera_1203, userId=644e456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d791894e1b4, moduleTitle=首批自主研发的新冠病毒抗体化学发光法检测试剂盒获准上市, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=1d791894e1b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005025, encodeId=6adf200502555, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, objectTitle=英法美三国准备进行大规模新冠病毒抗体检测，探测已获得免疫人群，以尽快恢复经济, objectType=article, longId=192057, objectId=a82119205ee4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a82119205ee4, replyNumber=0, likeNumber=65, createdTime=2020-08-21, rootId=0, userName=vera_1203, userId=644e456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a82119205ee4, moduleTitle=英法美三国准备进行大规模新冠病毒抗体检测，探测已获得免疫人群，以尽快恢复经济, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a82119205ee4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005028, encodeId=dec5200502854, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, objectTitle=浙江新冠病毒抗体检测定价40元，发热门诊患者可医保报销, objectType=article, longId=193730, objectId=e831193e304b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e831193e304b, replyNumber=0, likeNumber=59, createdTime=2020-11-24, rootId=0, userName=vera_1203, userId=644e456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e831193e304b, moduleTitle=浙江新冠病毒抗体检测定价40元，发热门诊患者可医保报销, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e831193e304b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005029, encodeId=29e620050290b, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, objectTitle=加拿大卫生部批准首例新冠病毒抗体的血清学测试, objectType=article, longId=194148, objectId=4528194148c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4528194148c3, replyNumber=0, likeNumber=66, createdTime=2021-02-19, rootId=0, userName=vera_1203, userId=644e456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4528194148c3, moduleTitle=加拿大卫生部批准首例新冠病毒抗体的血清学测试, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=4528194148c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

新冠病毒抗体

2020-05-29

vera_1203 (审核中...)

前往app查看评论内容

#新冠病毒抗体#

Nature：感染后产生的新冠病毒抗体，却成了导致重症和死亡的帮凶？

2022-09-20

vera_1203 (审核中...)

前往app查看评论内容

#新冠病毒抗体#

JAMA子刊：通过母乳将新冠病毒抗体传递给宝宝，孕妈妈该接种哪种疫苗？

2022-10-28

vera_1203 (审核中...)

前往app查看评论内容

#新冠病毒抗体#

Lancet：重磅！仅2.7%的武汉人群产生有效新冠病毒抗体

2021-09-04

vera_1203 (审核中...)

前往app查看评论内容

#新冠病毒抗体#

2021年3月20日全球新冠肺炎（COVID-19）疫情简报，确诊超1亿2286万，新冠病毒抗体可能维持达9个月，印度疫苗接种提速

2021-07-08

vera_1203 (审核中...)

前往app查看评论内容

#新冠病毒抗体#

君实与礼来制药达成2.55亿美元新冠病毒抗体授权合作！

2020-10-22

vera_1203 (审核中...)

前往app查看评论内容

#新冠病毒抗体#

罗氏新冠病毒抗体检测技术获美国FDA紧急使用授权

2021-03-13

vera_1203 (审核中...)

前往app查看评论内容

#新冠病毒抗体#

bioRxiv：科学家成功分离高效抗新冠病毒抗体

2020-08-25

vera_1203 (审核中...)

前往app查看评论内容

#新冠病毒抗体#

新冠病毒抗体检测，你知道对疫情防控有多重要吗？

2020-05-09

vera_1203 (审核中...)

前往app查看评论内容

#新冠病毒抗体#

三星制药和Vir生物技术公司签署了大规模生产新冠病毒抗体的协议，以治疗COVID-19

2021-02-03

vera_1203 (审核中...)

前往app查看评论内容

#新冠病毒抗体#

EClinicalMedicine：老年人产生新冠病毒抗体的能力不输年轻人

2020-12-07

vera_1203 (审核中...)

前往app查看评论内容

#新冠病毒抗体#

首批自主研发的新冠病毒抗体化学发光法检测试剂盒获准上市

2020-11-29

vera_1203 (审核中...)

前往app查看评论内容

#新冠病毒抗体#

英法美三国准备进行大规模新冠病毒抗体检测，探测已获得免疫人群，以尽快恢复经济

2020-08-21

vera_1203 (审核中...)

前往app查看评论内容

#新冠病毒抗体#

浙江新冠病毒抗体检测定价40元，发热门诊患者可医保报销

2020-11-24

vera_1203 (审核中...)

前往app查看评论内容

#新冠病毒抗体#

加拿大卫生部批准首例新冠病毒抗体的血清学测试

2021-02-19

科室
- - 订阅+
  - 更多科室
工具
服务